Hepatocellular carcinoma recurrence after liver transplantation: Risk factors, screening and clinical presentation
Author:
Publisher
Baishideng Publishing Group Inc.
Subject
Hepatology
Reference77 articles.
1. Hepatocellular Carcinoma Is the Most Common Indication for Liver Transplantation and Placement on the Waitlist in the United States
2. Liver Transplantation for the Treatment of Small Hepatocellular Carcinomas in Patients with Cirrhosis
3. Managements of recurrent hepatocellular carcinoma after liver transplantation: A systematic review
4. Prognosis after recurrence of hepatocellular carcinoma in liver transplantation: predictors for successful treatment and survival
5. Benefit of Treating Hepatocellular Carcinoma Recurrence after Liver Transplantation and Analysis of Prognostic Factors for Survival in a Large Euro-American Series
Cited by 77 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Immunotherapy and Liver Transplantation;Surgical Clinics of North America;2024-02
2. The Role of PIVKA-II as a Predictor of Early Hepatocellular Carcinoma Recurrence-Free Survival after Liver Transplantation in a Low Alpha-Fetoprotein Population;Cancers;2023-12-19
3. Hepatocellular carcinoma recurrence: Predictors and management;Liver Research;2023-12
4. Combining a deep learning model with clinical data better predicts hepatocellular carcinoma behavior following surgery;Journal of Pathology Informatics;2023-12
5. The impact of postoperative complications on oncological outcomes of liver transplantation for hepatocellular carcinoma: A competing risk analysis;Digestive and Liver Disease;2023-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3